发明名称 |
Análogos nucleosídicos con base monocíclica de carboxamidina modificada |
摘要 |
<p>The inventions relates to the use of the carboxamidine of Formula 1, or a pharmaceutically acceptable salt thereof, for the manufacture of a medicament for the treatment of a Hepatitis C Virus (HCV) viral infection or a Hepatitis B Virus (HBV) viral infection,
wherein the compound is in L-configuration or D-configuration.</p> |
申请公布号 |
ES2528429(T3) |
申请公布日期 |
2015.02.09 |
申请号 |
ES20070107588T |
申请日期 |
2001.02.15 |
申请人 |
VALEANT PHARMACEUTICALS NORTH AMERICA |
发明人 |
TAM, ROBERT;RAMASAMY, KANDA;HONG, ZHI;LAU, JOHNSON |
分类号 |
A61K31/70;A01P17/00;A61K31/7052;A61K31/7056;A61K31/7068;A61K38/21;A61P1/16;A61P3/10;A61P17/00;A61P19/02;A61P25/00;A61P25/28;A61P29/00;A61P31/12;A61P31/18;A61P33/00;A61P35/00;A61P37/02;C07H19/056;C07H19/14 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|